Netanya, Israel

Konstantin Ulanenko

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Netanya, IL (2014)
  • Natania, IL (2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Konstantin Ulanenko: Innovations in Pharmaceutical Chemistry

Introduction

Konstantin Ulanenko, an accomplished inventor based in Netanya, Israel, has made significant contributions to the field of pharmaceutical chemistry. With a total of three patents to his name, Ulanenko's work addresses vital aspects of drug composition and formulation, showcasing his expertise and commitment to advancing medical science.

Latest Patents

Ulanenko's latest patents are noteworthy for their innovative approaches to pharmaceutical compositions. The first patent addresses the compound N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide. This invention provides a pharmaceutical composition containing laquinimod or a pharmaceutically acceptable salt thereof, alongside Ulanenko's compound to enhance the drug's therapeutic efficacy.

His second patent focuses on N-ethyl-4-hydroxyl-1-methyl-5-(methyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide. This invention offers pharmaceutical compositions also involving laquinimod and outlines methods of preparation and the potential applications of the compound, aiming to provide improved treatment options for patients.

Career Highlights

Ulanenko's career is notably marked by his association with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva focuses on the development of innovative pharmaceutical solutions, demonstrating his ability to translate research into practical applications that can benefit public health.

Collaborations

Throughout his career, Ulanenko has collaborated with esteemed colleagues Avital Laxer and Vladimir Ioffe. Their combined expertise undoubtedly enriches the innovative environment at Teva Pharmaceutical Industries, leading to the development of groundbreaking pharmaceutical solutions.

Conclusion

Konstantin Ulanenko exemplifies the role of an inventor in the evolving landscape of pharmaceutical chemistry. His patents are a testament to his innovative spirit and dedication to improving healthcare through effective drug formulations. As he continues to contribute to the field, Ulanenko remains a notable figure in the landscape of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…